amiodarone has been researched along with Chylopericardium in 4 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Excerpt | Relevance | Reference |
---|---|---|
"A patient with sinuatrial disease and implanted pacemaker was treated with amiodarone (maximum dose 1000 mg, maintenance dose 800 mg daily) for 10 months, for control of supraventricular tachyarrhythmias." | 7.67 | Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy. ( Clarke, B; Honey, M; Ward, DE, 1985) |
" Repeat CT chest after 2 weeks for recurrent cough showed a small PE, treated with oral prednisone for suspected postablation pericarditis, with complete resolution of cough." | 3.88 | Cough as the sole manifestation of pericardial effusion. ( Abdullah, O; Fong, HK; Gautam, S, 2018) |
"We report a case with typical clinical features of drug-induced lupus erythematosus, together with verrucous endocarditis and pleuropericardial effusion, due to amiodarone treatment." | 3.71 | Drug-induced lupus erythematosus by amiodarone. ( Schäfer, U; Schnabel, A; Sheikhzadeh, A, 2002) |
"A patient with sinuatrial disease and implanted pacemaker was treated with amiodarone (maximum dose 1000 mg, maintenance dose 800 mg daily) for 10 months, for control of supraventricular tachyarrhythmias." | 3.67 | Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy. ( Clarke, B; Honey, M; Ward, DE, 1985) |
"VT recurrence was higher for >1RFA vs 1RFA (29% vs 24%, P <." | 1.46 | Outcomes after repeat ablation of ventricular tachycardia in structural heart disease: An analysis from the International VT Ablation Center Collaborative Group. ( Bunch, TJ; Burkhardt, JD; Callans, DJ; Della Bella, P; Di Biase, L; Dickfeld, T; Frankel, DS; Lakkireddy, D; Marchlinski, FE; Mathuria, N; Nakahara, S; Natale, A; Santangeli, P; Sauer, WH; Shivkumar, K; Stevenson, WG; Tedrow, U; Tholakanahalli, VN; Tung, R; Tzou, WS; Vakil, K; Vaseghi, M; Vergara, P; Vunnam, R; Weiss, JP, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tzou, WS | 1 |
Tung, R | 1 |
Frankel, DS | 1 |
Di Biase, L | 1 |
Santangeli, P | 1 |
Vaseghi, M | 1 |
Bunch, TJ | 1 |
Weiss, JP | 1 |
Tholakanahalli, VN | 1 |
Lakkireddy, D | 1 |
Vunnam, R | 1 |
Dickfeld, T | 1 |
Mathuria, N | 1 |
Tedrow, U | 1 |
Vergara, P | 1 |
Vakil, K | 1 |
Nakahara, S | 1 |
Burkhardt, JD | 1 |
Stevenson, WG | 1 |
Callans, DJ | 1 |
Della Bella, P | 1 |
Natale, A | 1 |
Shivkumar, K | 1 |
Marchlinski, FE | 1 |
Sauer, WH | 1 |
Fong, HK | 1 |
Abdullah, O | 1 |
Gautam, S | 1 |
Sheikhzadeh, A | 1 |
Schäfer, U | 1 |
Schnabel, A | 1 |
Clarke, B | 1 |
Ward, DE | 1 |
Honey, M | 1 |
4 other studies available for amiodarone and Chylopericardium
Article | Year |
---|---|
Outcomes after repeat ablation of ventricular tachycardia in structural heart disease: An analysis from the International VT Ablation Center Collaborative Group.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Electric Countershock; Electrocardiogra | 2017 |
Cough as the sole manifestation of pericardial effusion.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Cough; Echocardiography; | 2018 |
Drug-induced lupus erythematosus by amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antibodies, Antinuclear; C-Reactive Pr | 2002 |
Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy.
Topics: Adult; Amiodarone; Atrial Fibrillation; Atrial Flutter; Benzofurans; Combined Modality Therapy; Exer | 1985 |